Literature DB >> 16985606

Obesity and prostate cancer detection and progression.

Stephen J Freedland, Alan W Partin.   

Abstract

Entities:  

Year:  2004        PMID： 16985606      PMCID： PMC1472842     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  9 in total

1.  The continuing epidemic of obesity in the United States.

Authors:  A H Mokdad; M K Serdula; W H Dietz; B A Bowman; J S Marks; J P Koplan
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.

Authors:  C Rodriguez; A V Patel; E E Calle; E J Jacobs; A Chao; M J Thun
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-04       Impact factor: 4.254

3.  Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers.

Authors:  S O Andersson; A Wolk; R Bergström; H O Adami; G Engholm; A Englund; O Nyrén
Journal:  J Natl Cancer Inst       Date:  1997-03-05       Impact factor: 13.506

Review 4.  The underlying basis for obesity: relationship to cancer.

Authors:  George A Bray
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Body mass index and risk of prostate cancer in U.S. health professionals.

Authors:  Edward Giovannucci; Eric B Rimm; Yan Liu; Michael Leitzmann; Kana Wu; Meir J Stampfer; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

7.  Prevalence and trends in obesity among US adults, 1999-2000.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

8.  Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Authors:  Christopher L Amling; Robert H Riffenburgh; Leon Sun; Judd W Moul; Raymond S Lance; Leo Kusuda; Wade J Sexton; Douglas W Soderdahl; Timothy F Donahue; John P Foley; Andrew K Chung; David G McLeod
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

9.  Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

Authors:  Stephen J Freedland; William J Aronson; Christopher J Kane; Joseph C Presti; Christopher L Amling; David Elashoff; Martha K Terris
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544
  9 in total
  1 in total

1.  The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study.

Authors:  Lauren P Wallner; Hal Morgenstern; Michaela E McGree; Debra J Jacobson; Jennifer L St Sauver; Steven J Jacobsen; Aruna V Sarma
Journal:  Urology       Date:  2010-11-20       Impact factor: 2.649
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.